Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Key value for chemical safety assessment

Additional information

No specific study was performed on the absorption, distribution, metabolism and/or excretion (ADME) of WS400107, a complex mixture of components. Absorption and systemic availability of WS400107 after topical or oral administration are expected to be limited, because of its low water solubility, high lipohilicity (at acidic pH values) and, to some extent, its molecular weight (ca. 300 – 800). However, some dermal absorption of WS400107 or of a fraction of it has been concluded from the sensitization response attained in a Local Lymph Node Assay (LLNA) in mice at non-irritating test concentrations. In addition, absorption of at least some WS400107, components and/or metabolites of it after oral ingestion was inferred from changes in a number of blood plasma parameters indicative of altered hepatic function in rats after 5 weeks of treatment by oral gavage. In addition, reduced food intake and body weight gain were observed in males at 400 and 1000 mg/kg/day.

Exposure of humans to WS400107 by the inhalation route is unlikely, because of its very low vapour pressure (4 x 10-3Pa at 25°C), its decomposition at high temperature without boiling (> ca. 155°C) and because it is a highly viscous liquid.

All available study results gave no indication regarding the metabolic pathway, distribution or excretion of WS400107. The bioaccumulation potential cannot be judged based on the available studies.